SCHEMBL4953418

SCHEMBL4953418

CCSCCC(C(=O)O)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.48
BHMT Q93088 4/20 0.39
BHMT2 Q9H2M3 1/20 0.39
METAP2 P50579 4/20 0.39
CHRM1 P11229 1/20 0.39
AKR1A1 P14550 1/20 0.39
CHRM3 P20309 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
ADRA1A P35348 1/20 0.39
HRH1 P35367 1/20 0.39
DRD3 P35462 1/20 0.39
SLC6A3 Q01959 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
METAP1 P53582 2/20 0.38
GPR84 Q9NQS5 3/20 0.37
RNPEP Q9H4A4 1/20 0.37
FFAR1 O14842 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9463517 0.89 TSHR (0.43) TSHRBHMTBHMT2METAP2CHRM1
SCHEMBL4953619 0.83 BHMT (0.42) BHMTBHMT2CHRM1AKR1A1CHRM3
SCHEMBL721101 0.83 GPR84 (0.50) TSHRBHMTBHMT2METAP2CHRM1
Ethionine SCHEMBL7073863 0.79 BHMT (0.63) BHMTBHMT2NOS2NOS3NOS1
Ethionine SCHEMBL8966 0.79 BHMT (0.63) BHMTBHMT2NOS2NOS3NOS1
SCHEMBL9672379 0.79 CA2 (0.54) TSHRBHMTBHMT2METAP2CHRM1
Ethionine SCHEMBL8967 0.79 BHMT (0.63) BHMTBHMT2NOS2NOS3NOS1
SCHEMBL4955345 0.79 MAPT (0.45) TSHRBHMTBHMT2CHRM1AKR1A1
Ethionine SCHEMBL31567824 0.78 BHMT (0.61) BHMTBHMT2NOS2NOS3NOS1
Ethionine SCHEMBL11572299 0.78 BHMT (0.61) BHMTBHMT2NOS2NOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465471-B2 Palatability of aquaculture feed NOVUS INTERNATIONAL, INC. (US) 2008-12-16 US disclosed
WO-2007147155-A1 POLYOL ESTER COMPOUNDS NOVUS INTERNATIONAL INC. (US) 2007-12-21 WO disclosed
US-20070292485-A1 POLYOL ESTER COMPOUNDS NOVUS INTERNATIONAL INC. (US) 2007-12-20 US disclosed
US-20050215623-A1 Palatability of aquaculture feed NOVUS INTERNATIONAL, INC. (US) 2005-09-29 US disclosed
EP-1531672-A2 ANTIMICROBIAL COMPOSITIONS Novus International, Inc. (US) 2005-05-25 EP disclosed
US-20040175434-A1 Antimicrobial compositions NOVUS INTERNATIONAL, INC. 2004-09-09 US disclosed
WO-2004019683-A2 ANTIMICROBIAL COMPOSITIONS NOVUS INTERNATIONAL, INC. (US) 2004-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070292485-A1 POLYOL ESTER COMPOUNDS PNLIP, ELOVL1, ELOVL5 TSHR 4149/4885BHMT 2490/4885BHMT2 1311/4885
US-20050215623-A1 Palatability of aquaculture feed TAS2R3, TAS2R1, TAS2R20 TSHR 1282/4885BHMT 4314/4885BHMT2 3866/4885
US-20040175434-A1 Antimicrobial compositions MRPL21, FPR1, ARG1 TSHR 4028/4885BHMT 4126/4885BHMT2 4229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.